Literature DB >> 9686924

Fructose uptake in rat adipocytes: GLUT5 expression and the effects of streptozotocin-induced diabetes.

E Hajduch1, F Darakhshan, H S Hundal.   

Abstract

Previous studies have shown that rat adipocytes possess the capacity to take up fructose by a mechanism that is distinct from that involved in the transport of glucose. In this investigation we report that rat adipocytes express the GLUT5 fructose transporter and that it is responsible for mediating a substantial component (approximately 80%) of the total cellular fructose uptake. This proposition is based on the finding that only 21% of the total fructose uptake was cytochalasin B (CB) sensitive which most likely reflects transport via GLUT1 and/or GLUT4. Consistent with this suggestion we found (i) that insulin caused a small, but significant stimulation in fructose uptake (approximately 35%) which was abolished in the presence of CB and (ii) that 3-O-methyl glucose inhibited fructose uptake to a level comparable with that observed in the presence of CB. GLUT5 was found to be localised only in the adipocyte plasma membrane and, unlike GLUT4 or GLUT1, its cell surface abundance was not modulated by insulin. GLUT5 expression fell substantially (by approximately 75%) in adipocytes of streptozotocin-diabetic rats and was accompanied by a reduction in fructose uptake by approximately 50%. Treatment of streptozotocin-diabetic rats with sodium orthovanadate for a period of 3 days led to a significant reduction in blood glycaemia by approximately 40% and a partial restoration in both GLUT5 expression and adipocyte fructose uptake. We suggest that fructose uptake in rat adipocytes is principally mediated by GLUT5 in an insulin- and CB-insensitive manner and that expression of GLUT5 in rat adipocytes may be regulated by changes in blood glycaemia.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9686924     DOI: 10.1007/s001250050993

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  18 in total

1.  Subcellular localization and adaptive up-regulation of the System A (SAT2) amino acid transporter in skeletal-muscle cells and adipocytes.

Authors:  R Hyde; G R Christie; G J Litherland; E Hajduch; P M Taylor; H S Hundal
Journal:  Biochem J       Date:  2001-05-01       Impact factor: 3.857

2.  Irf5 deficiency in macrophages promotes beneficial adipose tissue expansion and insulin sensitivity during obesity.

Authors:  Elise Dalmas; Amine Toubal; Fawaz Alzaid; Katrina Blazek; Hayley L Eames; Kristell Lebozec; Maria Pini; Isabelle Hainault; Emilie Montastier; Raphaël G P Denis; Patricia Ancel; Amélie Lacombe; Yin Ling; Omran Allatif; Céline Cruciani-Guglielmacci; Sébastien André; Nathalie Viguerie; Christine Poitou; Vladimir Stich; Alexandra Torcivia; Fabienne Foufelle; Serge Luquet; Judith Aron-Wisnewsky; Dominique Langin; Karine Clément; Irina A Udalova; Nicolas Venteclef
Journal:  Nat Med       Date:  2015-05-04       Impact factor: 53.440

3.  Loss of the co-repressor GPS2 sensitizes macrophage activation upon metabolic stress induced by obesity and type 2 diabetes.

Authors:  Rongrong Fan; Amine Toubal; Saioa Goñi; Karima Drareni; Zhiqiang Huang; Fawaz Alzaid; Raphaelle Ballaire; Patricia Ancel; Ning Liang; Anastasios Damdimopoulos; Isabelle Hainault; Antoine Soprani; Judith Aron-Wisnewsky; Fabienne Foufelle; Toby Lawrence; Jean-Francois Gautier; Nicolas Venteclef; Eckardt Treuter
Journal:  Nat Med       Date:  2016-06-06       Impact factor: 53.440

Review 4.  Alternative therapies for diabetes and its cardiac complications: role of vanadium.

Authors:  Tod A Clark; Justin F Deniset; Clayton E Heyliger; Grant N Pierce
Journal:  Heart Fail Rev       Date:  2014-01       Impact factor: 4.214

5.  High fructose-mediated attenuation of insulin receptor signaling does not affect PDGF-induced proliferative signaling in vascular smooth muscle cells.

Authors:  Islam Osman; Ninu Poulose; Vadivel Ganapathy; Lakshman Segar
Journal:  Eur J Pharmacol       Date:  2016-10-08       Impact factor: 4.432

6.  Vitamin D Combined with Pioglitazone Mitigates Type-2 Diabetes-induced Hepatic Injury Through Targeting Inflammation, Apoptosis, and Oxidative Stress.

Authors:  Hend A Hamouda; Suzan M Mansour; Mohammed F Elyamany
Journal:  Inflammation       Date:  2021-09-01       Impact factor: 4.092

7.  Biochemical and functional characterization of the GLUT5 fructose transporter in rat skeletal muscle.

Authors:  F Darakhshan; E Hajduch; S Kristiansen; E A Richter; H S Hundal
Journal:  Biochem J       Date:  1998-12-01       Impact factor: 3.857

8.  Development of high-affinity ligands and photoaffinity labels for the D-fructose transporter GLUT5.

Authors:  Jing Yang; James Dowden; Arnaud Tatibouët; Yasumaru Hatanaka; Geoffrey D Holman
Journal:  Biochem J       Date:  2002-10-15       Impact factor: 3.857

9.  Metabolic and endocrine profiles in response to systemic infusion of fructose and glucose in rhesus macaques.

Authors:  Sean H Adams; Kimber L Stanhope; Ryan W Grant; Bethany P Cummings; Peter J Havel
Journal:  Endocrinology       Date:  2008-02-28       Impact factor: 4.736

Review 10.  Regulation of the fructose transporter GLUT5 in health and disease.

Authors:  Veronique Douard; Ronaldo P Ferraris
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-04-08       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.